PT  - JOURNAL ARTICLE
AU  - Vdovichenko, N
AU  - Voigt, A
AU  - Bolotin, R
AU  - Braeuer, M
AU  - Arampatzis, I
AU  - Blanke, P
AU  - Bahadur, A
AU  - Yadav, A
AU  - Mundhra, R
AU  - Chaturvedi, J
TI  - 11 The quality of life of patients with benign and malignant gynaecological tumors in himalayan region Rishikesh India
AID  - 10.1136/ijgc-2021-ESGO.566
DP  - 2021 Oct 01
TA  - International Journal of Gynecologic Cancer
PG  - A320--A320
VI  - 31
IP  - Suppl 3
4099  - http://ijgc.bmj.com/content/31/Suppl_3/A320.1.short
4100  - http://ijgc.bmj.com/content/31/Suppl_3/A320.1.full
SO  - Int J Gynecol Cancer2021 Oct 01; 31
AB  - Introduction/Background*QoL (Quality of life) of oncological and non-oncological patients is one of the most sensitive questions in gynecological care. We assessed the quality of life of gynecological patients with benign and malign diseases in our department and revealed the difference between the emotional, physical, spiritual, social/family, functional well-being, financial toxicity, treatment satisfaction with QoL score according to FACIT (Functional Assessment of Chronic Illness Therapy), histopathological type of cancer, BMI, marital status, main symptoms of the disease, age, education were also evaluated.Methodology QoL was assessed by the first visit, after intervention (operation, chemotherapy) by using FACIT Scoring.Result(s)*60 patients with a median age of 41,1 years (22-73) were evaluated. 32 females had histologically proven malignant and 28 had benign disease. Among malignant we found of 46,8% had endometrial, 21,8% ovary, 9,3% cervical, 9,3% vulvar, 3,1% breast cancer. The mean FACIT score in malignant group is 37,4 (34 -58,6) , lowest score observed by cervical cancer. The mean FACIT score in benign group is 37,2 (32,6-55) , lowest score observed by uterine fibroid 34,5. 85% of all patients had access to medical treatment. Lowest financial toxicity score was 5 by benign disease.Conclusion*Relative low and similar score of QoL in both group shows deficiency in disease care independently from dignity. It is required further investigation and improvement of quality of life in malignant and benign disease in gynaecological cases.